3/A

FORM 3/A SUBMISSION

Company: Acumen Pharmaceuticals, Inc.
Filed: July 8, 2021
Period of Report: June 30, 2021
Accession Number: 0001209191-21-046022

View Document ↗ View on SEC.gov ↗